ARCHIVES

Individualized Cancer Vaccines Show 90% Survival at 6 Months

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Rogers Bill Would Authorize $937 Million For NCI In ‘78

March 4, 1977

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

October 31, 2014

Bloch Pushes PDQ Promotion To Public, But NCAB Limits It to Physicians

February 17, 1984

DCT Board Approves Concept For BRMP Master Agreement

June 26, 1987

Broder; Cancer Act’s Special Authorities Don’t Give Director Immunity For NIH, HHS

September 27, 1991

President’s Cancer Panel Urges Greater Emphasis On Prevention.

September 21, 2007